GS
DXCM icon

GTS Securities’s DexCom DXCM Stock Holding History

GTS Securities’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,362
Closed -$274K – 1470
2026
Q1 		$274K Sell
4,362
-1,296
-23% -$90.3K 0.01% 1156
2025
Q4 		$376K Sell
5,658
-4,956
-47% -$320K 0.01% 941
2025
Q3 		$714K Buy
+10,614
New +$840K 0.03% 566
2025
Q2 		– Sell
-5,251
Closed -$359K – 1321
2025
Q1 		$359K Buy
5,251
+1,896
+57% +$155K 0.02% 857
2024
Q4 		$261K Sell
3,355
-35,801
-91% -$2.65M 0.01% 971
2024
Q3 		$2.63M Buy
39,156
+27,824
+246% +$2.28M 0.01% 1372
2024
Q2 		$1.28M Buy
+11,332
New +$1.43M ﹤0.01% 1850
2024
Q1 		– Sell
-3,527
Closed -$443K – 3978
2023
Q4 		$438K Sell
3,527
-8,983
-72% -$918K ﹤0.01% 2899
2023
Q3 		$1.17M Buy
12,510
+5,901
+89% +$665K ﹤0.01% 1895
2023
Q2 		$849K Buy
+6,609
New +$799K 0.03% 473

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GTS Securities's DXCM Position: Q2 2026 in Review

GTS Securities sold out of DexCom (DXCM) in Q2 2026, closing a stake of 4,362 shares — an estimated $274K sold.

GTS Securities first reported a position in DXCM in Q2 2023 and held it in 10 quarters. The position peaked at $2.63M in Q3 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • GTS Securities reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 4,362 DexCom shares in Q2 2026, an estimated $274K.
  • GTS Securities first reported a position in DexCom in Q2 2023 and held it in 10 quarters.
  • GTS Securities's DexCom position peaked at $2.63M in Q3 2024.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.